HOXA7: Key Regulator of Embryonic Development and Disease (G3204)

Target Name: HOXA7

NCBI ID: G3204

HOXA7

HOXA7: Key Regulator of Embryonic Development and Disease

Homeobox A7 (HOXA7) is a non-coding RNA molecule that is expressed in various tissues of the body. It is a key regulator of gene expression in development and tissue homeostasis, and is involved in the formation of tissues and organs during embryonic development. HOXA7 has also been implicated in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, it is of great interest to study HOXA7 and its potential as a drug target or biomarker.

Expression and Functions

HOXA7 is expressed in a variety of tissues, including muscle, heart, kidney, liver, and brain. It is highly expressed in the brain, where it is the highest expressed gene in the nervous system. HOXA7 is also expressed in the heart, where it is highly expressed in the cardiac muscle. In the lungs, it is expressed in the epithelial cells, and in the liver, it is expressed in the hepatocytes.

HOXA7 plays a crucial role in the formation of tissues and organs during embryonic development. It is involved in the development of the neural tube, which forms the brain and spinal cord. HOXA7 is also involved in the formation of the heart and the circulatory system. It is expressed in the cardiac muscle and is involved in the development of the heart valves.

HOXA7 is also involved in the regulation of cell survival and apoptosis. It has been shown to play a role in the regulation of cell cycle progression, and is involved in the formation of apoptotic cells. This may have implications for the development of cancer.

HOXA7 and Disease

HOXA7 has been implicated in the development and progression of several diseases. One of the most well-studied is cancer. Cancer is a disease that is characterized by the formation of tumors, which can be benign or malignant. HOXA7 has been shown to play a role in the development and progression of several types of cancer, including breast, ovarian, and prostate cancer.

HOXA7 has also been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. HOXA7 has been shown to play a role in the regulation of neurodegenerative disease progression.

HOXA7 has also been implicated in the development of autoimmune disorders, such as rheumatoid arthritis and lupus. These conditions are characterized by the immune system attacking the body's own tissues. HOXA7 has been shown to play a role in the regulation of autoimmune disease progression.

Drug Targeting

HOXA7 is a potential drug target for the treatment of various diseases. One of the most promising strategies for targeting HOXA7 is the use of small molecules that can modulate its expression and activity. This includes the use of inhibitors of the HOXA7 enzyme, as well as the use of drugs that can modulate its downstream targets.

An inhibitor of the HOXA7 enzyme, called 2-Clostridium Butyricum (CBY), has been shown to be effective in the treatment of cancer. CBY inhibits the activity of the HOXA7 enzyme and has been shown to have anti-cancer effects.

Another potential drug that can target HOXA7 is the small molecule, 2-methoxybenzethiazole (2-MBZ). 2-MBZ is a inhibitor of the HOXA7 enzyme and has been shown to have anti-cancer effects.

Biomarker

HOXA7 can also be used as a biomarker for the diagnosis and monitoring of various diseases. For example, HOXA7 levels have been used as a biomarker for the diagnosis of cancer, as the levels of HOXA7 tend to increase in cancer cells.

HOXA7 levels have also been used as a biomarker for the diagnosis of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease

Protein Name: Homeobox A7

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXA7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXA7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets